Company profile for Neuraxpharm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Neuraxpharm is a European leader in pharmaceuticals for disorders affecting the central nervous system (CNS). We are specialists in this field since 1985 and our more than 35 years’ experience bring a broad, unparalleled knowledge into our research and final products. We are experts in improving existing pharmaceutical forms and upgrading new products with the aim to deliver relevant improvements in the life and wellbeing of...
Neuraxpharm is a European leader in pharmaceuticals for disorders affecting the central nervous system (CNS). We are specialists in this field since 1985 and our more than 35 years’ experience bring a broad, unparalleled knowledge into our research and final products. We are experts in improving existing pharmaceutical forms and upgrading new products with the aim to deliver relevant improvements in the life and wellbeing of patients with neurological and psychiatric disorders. We are guided by excellence, scientific rigour, quality and perseverance.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Avda. Barcelona, 69 08970 Sant Joan Despí Barcelona
Telephone
Telephone
+34 93 475 96 00
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-27/neuraxpharm-and-mjn-neuro-announce-plans-to-launch-episeras-a-digital-health-solution-using-an-ai-powered-wearable-device-for-the-early-detection-of

PHARMIWEB
27 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-02/neuraxpharm-strengthens-multiple-sclerosis-portfolio-with-the-launch-of-riulvy-tegomil-fumarate

PHARMAWEB
02 Oct 2025

https://www.pharmiweb.com/press-release/2025-09-23/new-ublituximab-data-in-multiple-sclerosis-to-be-presented-at-ectrims-congress-2025-alongside-partner-tg-therapeutics

PHARMAWEB
23 Sep 2025

https://www.prnewswire.com/news-releases/neuraxpharm-participates-in-ectrims-reinforcing-its-commitment-to-multiple-sclerosis-302563080.html

PR NEWSWIRE
22 Sep 2025

https://www.prnewswire.com/news-releases/neuraxpharm-continues-international-expansion-with-launch-of-neuraxpharm-australia-302509671.html

PR NEWSWIRE
21 Jul 2025

https://www.prnewswire.com/news-releases/neuraxpharm-and-dizlin-pharmaceuticals-announce-global-strategic-co-development-agreement-bringing-next-generation-drug-device-therapy-to-patients-with-advanced-parkinsons-disease-302499086.html

PR NEWSWIRE
09 Jul 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty